Ad-NIS (Gencell)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAd-NIS (Gencell)
Drug Alias Nameoncolytic adenovirus therapy expressing sodium iodide symporter (Centelion)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionSodium/iodide cotransporter stimulants
TargetsSodium/iodide cotransporter
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentelion SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A